Evidence map›Paper›PMID 21256200›Full record

ArticleGene2011

High content imaging-based assay to classify estrogen receptor-α ligands based on defined mechanistic outcomes.

F J Ashcroft, J Y Newberg, E D Jones, I Mikic, M A Mancini

Open access · greenAbstract read
In one paragraph

Article in Gene, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Binary Classification of the Endocrine Disrupting Chemicals by Artificial Neural Networks.ESCAPE. European Symposium on Computer Aided Process Engineering · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Mitochondrial Epigenetics and Environmental Health: Making a Case for Endocrine Disrupting Chemicals.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

F J AshcroftDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
J Y Newberg
E D Jones
I Mikic
M A Mancini
Baylor College of Medicine · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 1998 to 2013
$19.9M
STEROID RECEPTOR FUNCTION AND NUCLEAR ORGANIZATIONR01DK055622 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MANCINI, MICHAEL A · 1999 to 2007
$2.1M
Developmental Reprogramming of Prostate Carcinogenesis by BPARC2ES018789 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HO, SHUK-MEI, MANCINI, MICHAEL A. · 2009 to 2010
$1.9M
ANALYSIS OF PITUITARY-SPECIFIC TRANSCRIPTION FACTORSF32DK008301 · NIDDK · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI BRADY, HELEN A · 1989 to 1991
–
NCI NIH HHS P30 CA-125123NCI NIH HHS P30 CA125123NICHD NIH HHS U54 HD-007495NICHD NIH HHS U54 HD007495NIDDK NIH HHS 5R01DK055622NIDDK NIH HHS K12-DK0830140-02NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK-56338NIDDK NIH HHS R01 DK055622NIEHS NIH HHS 5RC2ES018789-02NIEHS NIH HHS RC2 ES018789
6 · The paper itself

Abstract

Estrogen receptor-α (ER) is an important target both for therapeutic compounds and endocrine disrupting chemicals (EDCs); however, the mechanisms involved in chemical modulation of regulating ER transcriptional activity are inadequately understood. Here, we report the development of a high content analysis-based assay to describe ER activity that uniquely exploits a microscopically visible multi-copy integration of an ER-regulated promoter. Through automated single-cell analyses, we simultaneously quantified promoter occupancy, recruitment of transcriptional cofactors and large-scale chromatin changes in response to a panel of ER ligands and EDCs. Image-derived multi-parametric data was used to classify a panel of ligand responses at high resolution. We propose this system as a novel technology providing new mechanistic insights into EDC activities in a manner useful for both basic mechanistic studies and drug testing.

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsBlotting, WesternCell Line, TumorCluster AnalysisEndocrine DisruptorsEstradiolEstrogen AntagonistsEstrogen Receptor alphaFulvestrantGreen Fluorescent ProteinsHeLa CellsHumansMicroscopy, FluorescencePhenolsPrincipal Component AnalysisafimoxifeneBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsEstradiolEstrogen AntagonistsEstrogen Receptor alphaFulvestrantGreen Fluorescent ProteinsPhenolsRaloxifene HydrochlorideTamoxifen

Identifiers

PMID21256200
PMCPMC3086628
OpenAlexW2051656824

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.